The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Methotrexate an Old Drug with New Tricks
Open accessAbstract
Methotrexate (MTX) is the first line drug for the treatment of a number of rheumatic and non-rheumatic disorders. It is currently used as an anchor disease, modifying anti-rheumatic drug in the treatment of rheumatoid arthritis (RA). Despite the development of numerous new targeted therapies, MTX remains the backbone of RA therapy due to its potent efficacy and tolerability. There has been also a growing interest in the use of MTX in the treatment of chronic viral mediated arthritis. Many viruses—including old world alphaviruses, Parvovirus B19, hepatitis B/C virus, and human immunodeficiency virus—have been associated with arthritogenic diseases and reminiscent of RA. MTX may provide benefits although with the potential risk of attenuating patients’ immune surveillance capacities. In this review, we describe the emerging mechanisms of action of MTX as an anti-inflammatory drug and complementing its well-established immunomodulatory activity. The mechanisms involve adenosine signaling modulation, alteration of cytokine networks, generation of reactive oxygen species and HMGB1 alarmin suppression. We also provide a comprehensive understanding of the mechanisms of MTX toxic effects. Lastly, we discussed the efficacy, as well as the safety, of MTX used in the management of viral-related rheumatic syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M., Moreland, L. W., O'Dell, J., Winthrop, K. L., Beukelman, T., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21641 · Cited by 1,789
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
O'Shea, J. J., & Plenge, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.014 · Cited by 1,138
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E., Coblyn, J. S., Fox, D. A., Fraser, P. A., Holdsworth, D. E., Glass, D. N., & Trentham, D. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121303 · Cited by 872
NF‐κB in inflammatory bowel disease
Atreya, I., Atreya, R., & Neurath, M. F. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01953.x · Cited by 812
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Understanding and Managing Methotrexate Nephrotoxicity
Widemann, B. C., & Adamson, P. C. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-694 · Cited by 730
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Salliot, C., & van der Heijde, D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093690 · Cited by 673
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wang, W., Zhou, H., & Liu, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.027 · Cited by 562
Predictors of infection in rheumatoid arthritis
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10529 · Cited by 560
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Arthritogenic alphaviruses—an overview
Suhrbier, A., Jaffar-Bandjee, M.-C., & Gasque, P. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.64 · Cited by 489
Self-citationTaniguchi, N., Kawahara, K., Yone, K., Hashiguchi, T., Yamakuchi, M., Goto, M., Inoue, K., Yamada, S., Ijiri, K., Matsunaga, S., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10859 · Cited by 482
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
Smolen, J. S., & Aletaha, D. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.8 · Cited by 474
Polyglutamation of methotrexate. Is methotrexate a prodrug?
Chabner, B. A., Allegra, C. J., Curt, G. A., Clendeninn, N. J., Baram, J., Koizumi, S., Drake, J. C., & Jolivet, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112088 · Cited by 460
Methotrexate—how does it really work?
Chan, E. S. L., & Cronstein, B. N. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.5 · Cited by 459
Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., & Revillard, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2676 · Cited by 459
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
CUTOLO, M., SULLI, A., PIZZORNI, C., SERIOLO, B., & STRAUB, R. H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.8.729 · Cited by 433
Mechanisms of action of methotrexate
Genestier, L., Paillot, R., Quemeneur, L., Izeradjene, K., & Revillard, J.-P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00189-2 · Cited by 424
Makarov, S. S. (2001) · Arthritis Research · doi:10.1186/ar300 · Cited by 412
Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N., & Klareskog, L. (1998) · BMJ · doi:10.1136/bmj.317.7152.180 · Cited by 394
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Brown, P. M., Pratt, A. G., & Isaacs, J. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.175 · Cited by 382
Regulation of Inflammation by Adenosine
Haskó, G., & Cronstein, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00085 · Cited by 367
Morgan, S. L., Baggott, J. E., Vaughn, W. H., Austin, J. S., Veitch, T. A., Lee, J. Y., Koopman, W. J., Krumdieck, C. L., & Alarcon, G. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00002 · Cited by 360
Tian, H., & Cronstein, B. N. (2007) · PubMed · Cited by 351
GUBNER, R. S., August, S., & Ginsberg, V. (1951) · PubMed · Cited by 343
Chalupsky, K., & Cai, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409594102 · Cited by 339
Cronstein, B. N., Eberle, M. A., Gruber, H. E., & Levin, R. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2441 · Cited by 332
Visser, K., & van der Heijde, D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092668 · Cited by 328
Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
Curtis, J. R., & Singh, J. A. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.05.044 · Cited by 326
Kokkola, R., Li, J., Sundberg, E., Aveberger, A. ‐., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., & Harris, H. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11161 · Cited by 325
Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?
Burmester, G. R., Stuhlmüller, B., Keyszer, G., & Kinne, R. W. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400104 · Cited by 318
Matrix metalloproteinases in arthritic disease.
Murphy, G., Knäuper, V., Atkinson, S. J., Butler, G., English, W., Hutton, M., Stracke, J. O., & Clark, I. M. (2002) · Arthritis Research · doi:10.1186/ar572 · Cited by 313
THE MECHANISM OF ACTION OF METHOTREXATE
Cronstein, B. N. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70358-6 · Cited by 312
Gubner, R., August, S., & Ginsberg, V. (1951) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195102000-00009 · Cited by 308
High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis
Kokkola, R., Sundberg, E., Ulfgren, A. ‐., Palmblad, K., Li, J., Wang, H., Ulloa, L., Yang, H., Yan, X. ‐., Furie, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10540 · Cited by 290
The risk of hospitalized infection in patients with rheumatoid arthritis.
Smitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A., & Chan, K. A. (2008) · PubMed · Cited by 281
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis
Bernatsky, S., Hudson, M., & Suissa, S. (2007) · Rheumatology · doi:10.1093/rheumatology/kem076 · Cited by 281
Stichtenoth, D. O., Thorén, S., Bian, H., Peters-Golden, M., Jakobsson, P.-J., & Crofford, L. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.469 · Cited by 269
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
Cronstein, B. N., & Sitkovsky, M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.178 · Cited by 258
Wessels, J. A. M., van der Kooij, S. M., le Cessie, S., Kievit, W., Barerra, P., Allaart, C. F., Huizinga, T. W. J., Guchelaar, H., & Pharmacogenetics Collaborative Research Group (2007) · Arthritis & Rheumatism · doi:10.1002/art.22640 · Cited by 247
Javelle, E., Ribera, A., Degasne, I., Gaüzère, B.-A., Marimoutou, C., & Simon, F. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003603 · Cited by 243
Abolmaali, S. S., Tamaddon, A. M., & Dinarvand, R. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2062-0 · Cited by 240
Adenosine A2Areceptors play a role in the pathogenesis of hepatic cirrhosis
Chan, E. S. L., Montesinos, M. C., Fernandez, P., Desai, A., Delano, D. L., Yee, H., Reiss, A. B., Pillinger, M. H., Chen, J., Schwarzschild, M. A., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706812 · Cited by 229
Hoekstra, M., HAAGSMA, C. J., Neef, C., Proost, J. H., Knuif, A., & van de Laar, M. A. F. J. (2004) · PubMed · Cited by 220
Kremer, J. M., Galivan, J., Streckfuss, A., & Kamen, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290703 · Cited by 217
Ostuni, P., Botsios, C., Punzi, L., Sfriso, P., & Todesco, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.686 · Cited by 217
Montesinos, M. C., Desai, A., Delano, D., Chen, J., Fink, J. S., Jacobson, M. A., & Cronstein, B. N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10712 · Cited by 213
Schiff, M. H., Jaffe, J. S., & Freundlich, B. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205228 · Cited by 211
Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid Arthritis
Bannwarth, B., Péhourcq, F., Schaeverbeke, T., & Dehais, J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630030-00002 · Cited by 206
Baggott, J. E., Vaughn, W. H., & Hudson, B. B. (1986) · Biochemical Journal · doi:10.1042/bj2360193 · Cited by 205
Gerards, A. H. (2003) · Rheumatology · doi:10.1093/rheumatology/keg323 · Cited by 205
The pharmacology of methotrexate
Olsen, E. A. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70199-c · Cited by 192
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis
Pullerits, R., Jonsson, I., Verdrengh, M., Bokarewa, M., Andersson, U., Erlandsson‐Harris, H., & Tarkowski, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11028 · Cited by 191
Quinn, C. T., Griener, J. C., Bottiglieri, T., Hyland, K., Farrow, A., & Kamen, B. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2800 · Cited by 189
Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
Vincenti, M. P., Clark, I. M., & Brinckerhoff, C. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370802 · Cited by 188
Montesinos, M. C., Yap, J. S., Desai, A., Posadas, I., McCrary, C. T., & Cronstein, B. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<656::aid-anr23>3.0.co;2-h · Cited by 186
Kamel, O. W., van de Rijn, M., LeBrun, D. P., Weiss, L. M., Warnke, R. A., & Dorfman, R. F. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90295-x · Cited by 185
Phillips, D. C., Woollard, K. J., & Griffiths, H. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705054 · Cited by 183
p53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism
Ak, P., & Levine, A. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-160549 · Cited by 178
Merrill, J. T., Shen, C. P., Schreibman, D., Coffey, D., Zakharenko, O., Fisher, R. C., Lahita, R. G., Salmon, J. E., & Cronstein, B. N. (1997) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199707)40:7<1308::aid-art16>3.0.co;2-m · Cited by 174
Herman, S., Zurgil, N., & Deutsch, M. (2005) · Inflammation Research · doi:10.1007/s00011-005-1355-8 · Cited by 173
Inoue, K., & Yuasa, H. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rv-119 · Cited by 172
Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate.
Puig, J. G., & Fox, I. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111512 · Cited by 172
Risk of liver disease in methotrexate treated patients
Conway, R., & Carey, J. J. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i26.1092 · Cited by 170
Hepatotoxicity related to antirheumatic drugs
Aithal, G. P. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.214 · Cited by 170
Methotrexate Is a JAK/STAT Pathway Inhibitor
Thomas, S., Fisher, K. H., Snowden, J. A., Danson, S. J., Brown, S., & Zeidler, M. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130078 · Cited by 168
Methotrexate in Rheumatoid Arthritis: An Update
Bannwarth, B., Labat, L., Moride, Y., & Schaeverbeke, T. (1994) · Drugs · doi:10.2165/00003495-199447010-00003 · Cited by 168
Methotrexate in rheumatoid arthritis
Furst, D. E., & Kremer, J. M. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310301 · Cited by 163
Aminophylline for methotrexate-induced neurotoxicity
Bernini, J. C., Fort, D. W., Griener, J. C., Kane, B. J., Chappell, W. B., Kamen, B. A., & Kamen, B. A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90464-6 · Cited by 163
Goupil, B. A., & Mores, C. N. (2016) · The Open Rheumatology Journal · doi:10.2174/1874312901610010129 · Cited by 162
Methotrexate Inhibits NF‐κB Activity Via Long Intergenic (Noncoding) RNA–p21 Induction
Spurlock, C. F., Tossberg, J. T., Matlock, B. K., Olsen, N. J., & Aune, T. M. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38805 · Cited by 161
It takes two to tango: IκBs, the multifunctional partners of NF‐κB
Hinz, M., Arslan, S. Ç., & Scheidereit, C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01102.x · Cited by 160
The human proton-coupled folate transporter
Desmoulin, S. K., Hou, Z., Gangjee, A., & Matherly, L. H. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.22020 · Cited by 158
Immunosuppressive and Cytotoxic Pharmacotherapy for Pulmonary Disorders
Lynch, J. P., & McCune, W. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032171 · Cited by 153
Multiple congenital anomalies associated with weekly low‐dose methotrexate treatment of the mother
Buckley, L. M., Bullaboy, C. A., Leichtman, L. G., & Marquez, M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400527 · Cited by 151
Abelson, H. T., Fosburg, M. T., Beardsley, G. P., et al. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.3.208 · Cited by 149
Prey, S., & Paul, C. F. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08876.x · Cited by 149
Methotrexate pulmonary toxicity
Lateef, O., Shakoor, N., & BALK, R. A. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.4.723 · Cited by 147
Dolhain, R., Tak, P. P., Dijkmans, B. A. C., et al. (1998) · Lara D. Veeken · doi:10.1093/rheumatology/37.5.502 · Cited by 146
Marks, M., & Marks, J. L. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-2-129 · Cited by 142
Crabtree, M. J., Hale, A., & Channon, K. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.010 · Cited by 140
Varani, K., J, M. P. J., Vincenzi, F., Targa, M., Trotta, F., Govoni, M., & Borea, P. A. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3527 · Cited by 139
Miranda‐Carús, M., Balsa, A., Benito, M., de Ayala, C. P., & Martín-Mola, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1463 · Cited by 138
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
Emery, P., Sebba, A. I., & Huizinga, T. W. J. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203485 · Cited by 136
Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss
Chen, W., Foo, S., Rulli, N. E., Taylor, A., Sheng, K., Herrero, L. J., Herring, B. L., Lidbury, B. A., Li, R., Walsh, N. C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318859111 · Cited by 133
The effects of methotrexate on the production and activity of interleukin‐1
Segal, R., Mozes, E., Yaron, M., et al. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320403 · Cited by 133
van der Veen, M. J., van der Heide, A., Kruize, A. A., & Bijlsma, J. W. J. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.4.224 · Cited by 131
Thakkar, M. M., Engemann, S. C., Walsh, K., & Sahota, P. K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.017 · Cited by 128
Methotrexate, rheumatoid arthritis and infection risk--what is the evidence?
McLean‐Tooke, A. P., Aldridge, C., Waugh, S., Spickett, G. P., & Kay, L. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep101 · Cited by 128
Nakaya, H. I., Gardner, J., Poo, Y. S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34631 · Cited by 123
Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium
Westman, M., Korotkova, M., af Klint, E., Stark, A., Audoly, L., Klareskog, L., Ulfgren, A.-K., & Jakobsson, P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20286 · Cited by 119
Che, J., Chan, E. S. L., & Cronstein, B. N. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038760 · Cited by 119
Neurath, M. F., Hildner, K., Becker, C., Schlaak, J., Barbulescu, K., Germann, T., Schmitt, E., Schirmacher, P., Haralambous, S., Pasparakis, M., et al. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00753.x · Cited by 118
The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?
Ivashkiv, L., & Hu, X.-Y. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11095 · Cited by 118
Constantin, A., Loubet‐Lescoulié, P., Lambert, N. C., Yassine‐Diab, B., Abbal, M., Mazi�res, B., de Pr�val, C., & Cantagrel, A. G. (1998) · Arthritis & Rheumatism · Cited by 117
Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
Ganu, M. A., & Ganu, A. (2011) · PubMed · Cited by 115
Protective Effect of β-Carotene on Methotrexate–Induced Oxidative Liver Damage
Vardı, N., Parlakpınar, H., Çetin, A., et al. (2010) · Toxicologic Pathology · doi:10.1177/0192623310367806 · Cited by 112
High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
Castiglioni, A., Canti, V., Rovere, P. Q., & Manfredi, A. A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1033-1 · Cited by 111
Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
Bello, A. E., Perkins, E., Jay, R., et al. (2017) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s131668 · Cited by 111
Bressolle, F., Bologna, C., Kinowski, J., Sany, J., & Combe, B. G. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.2.110 · Cited by 110
Sung, J., Hong, J. H., Kang, H.-S., Choi, I., Lim, S.-D., Lee, J.-K., Seok, J.-H., Lee, J.-H., & Hur, G. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(99)00185-x · Cited by 108
Fairbanks, L. D., Rückemann-Dziurdzińska, K., Ying, Q. I. U., et al. (1999) · Biochemical Journal · doi:10.1042/bj3420143 · Cited by 108
Methotrexate modulates the kinetics of adenosine in humans in vivo
Riksen, N. P., Barrera, P., van den Broek, P. H. H., van Riel, P. L. C. M., Smits, P., & Rongen, G. A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048637 · Cited by 106
Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis
Miner, J. J., Cook, L. E., Hong, J. P., Smith, A. M., Richner, J. M., Shimak, R. M. K., Young, A. R., Monte, K. J., Poddar, S., Crowe, J. E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah3438 · Cited by 106
Advanced Glycation End Product Receptor‐Mediated Cellular Dysfunction
Bierhaus, A., Humpert, P. M., Stern, D. M., Arnold, B., & Nawroth, P. P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.077 · Cited by 102
Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis
Nesher, G., Mates, M., & Zevin, S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10766 · Cited by 99
Mok, M. Y., Ng, W. L., Yuen, M., et al. (2000) · PubMed · Cited by 91
NF‐κB: Holy Grail for rheumatoid arthritis?
Firestein, G. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20468 · Cited by 89
The incidence of cancer associated with the treatmentof rheumatoid arthritis
Beauparlant, P., Papp, K. A., & Haraoui, B. P. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80026-2 · Cited by 88
Montesinos, M. C., Desai, A., & Cronstein, B. N. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1914 · Cited by 87
Rudwaleit, M., Yin, Z., Siegert, S., Grolms, M., Radbruch, A., Braun, J., & Sieper, J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.4.311 · Cited by 85
Garg, N. K., Singh, B., Tyagi, R. K., Sharma, G., & Katare, O. P. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.07.046 · Cited by 85
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway
Kim, Y., Song, M., & Ryu, J. (2008) · Toxicology · doi:10.1016/j.tox.2008.11.016 · Cited by 79
Spurlock, C. F., Gass, H. M., Bryant, C. J., Wells, B. C., Olsen, N. J., & Aune, T. M. (2014) · Rheumatology · doi:10.1093/rheumatology/keu279 · Cited by 74
Brody, M., Böhm, I., & Bauer, R. (1993) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1993.31.10.667 · Cited by 73
Paul, M., Hemshekhar, M., Thushara, R. M., Sundaram, M. S., NaveenKumar, S. K., Naveen, S., Sannaningaiah, D., Somyajit, K., West, R., Basappa, B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127558 · Cited by 73
Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro
Ohbayashi, M., Suzuki, M., Yashiro, Y., Fukuwaka, S., Yasuda, M., Kohyama, N., Kobayashi, Y., & Yamamoto, T. (2010) · The Journal of Toxicological Sciences · doi:10.2131/jts.35.653 · Cited by 71
The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis
Chen, Y., Sun, W., Gao, R., Su, Y., Umehara, H., Dong, L., & Gong, F. (2013) · Rheumatology · doi:10.1093/rheumatology/ket134 · Cited by 71
Mechanisms of viral pathogenesis in rheumatic disease
Perl, A. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.8.454 · Cited by 70
Çelik, İ., Krack, W., Zeiler, T. A., Kretschmer, V., Solinas, S., Gajek, H., & Lorenz, W. (2001) · Inflammation Research · doi:10.1007/s000110050726 · Cited by 67
A systematic review of viral exposures as a risk for rheumatoid arthritis
Kudaeva, F. M., Speechley, M. R., & Pope, J. E. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.03.011 · Cited by 63
Mechanisms of action of methotrexate.
Chan, E. S. L., & Cronstein, B. N. (2013) · PubMed · Cited by 62
Tamura, T., Higuchi, Y., Kitamura, H., Murao, N., Saitoh, R., Morikawa, T., & Sato, H. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0971-8 · Cited by 61
Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action
Stamp, L. K., Hazlett, J., Roberts, R. L., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3871 · Cited by 60
Wijngaarden, S., van Roon, J. A. G., van de Winkel, J. G. J., Bijlsma, J. W. J., & Lafeber, F. P. J. G. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh583 · Cited by 55
Goodman, S. M., Cronstein, B. N., & Bykerk, V. P. (2015) · PubMed · Cited by 55
Treatment of Chronic Chikungunya Arthritis With Methotrexate: A Systematic Review
Amaral, J. K., Sutaria, R., & Schoen, R. T. (2018) · Arthritis Care & Research · doi:10.1002/acr.23519 · Cited by 55
Qiu, Q., Huang, J., Shu, X., Fan, H., Zhou, Y., & Xiao, C. (2017) · Scientific Reports · doi:10.1038/srep44015 · Cited by 54
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients
MATURA, O. B. O. T., Taylor, J., PAMERA, A., Consortia, Bongartz, T., Massey, J., Mifsud, B., Spiliopoulou, A., Scott, I. C., Wang, J., et al. (2018) · The Pharmacogenomics Journal · doi:10.1038/s41397-018-0025-5 · Cited by 54
Senapati, S., Singh, S. T., Das, M., Kumar, A., Gupta, R., Kumar, U., Jain, S. K., Juyal, R. C., & Thelma, B. K. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000036 · Cited by 53
Biliary elimination of low‐dose methotrexate in humans
Nürnberg, B., Koehnke, R., Solsky, M. A., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330620 · Cited by 53
Chronic liver injury induced by drugs and toxins
Ortega‐Alonso, A., & Andrade, R. J. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12612 · Cited by 53
Childhood Arthritis Response to Medication Study (CHARMS), C. A. P. S. (., Cobb, J. E., Cule, E., Moncrieffe, H., Hinks, A., Ursu, S., Patrick, F., Kassoumeri, L., Flynn, E., Bulatović-Ćalasan, M., et al. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.3 · Cited by 52
Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis.
Yukioka, K., Wakitani, S., Yukioka, M., et al. (1992) · PubMed · Cited by 51
Renal effects of low dose methotrexate in rheumatoid arthritis.
Seideman, P., Müller-Suur, R., & Ekman, E. (1993) · PubMed · Cited by 49
Kuroiwa, Y., Takakusagi, Y., Kusayanagi, T., Kuramochi, K., Imai, T., Hirayama, T., Ito, I., Yoshida, M., Sakaguchi, K., & Sugawara, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063073 · Cited by 46
p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion
Seemayer, C. A., Kuchen, S., Neidhart, M., Kuenzler, P., Řihošková, V., Neumann, E., Pruschy, M. N., Aicher, W. K., Müller-Ladner, U., Gay, R. E., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.007401 · Cited by 45
Williams, A. S., Goodfellow, R., Topley, N., Amos, N., & Williams, B. (2000) · Inflammation Research · doi:10.1007/s000110050575 · Cited by 42
Murakami, T., & Mori, N. (2012) · Pharmaceuticals · doi:10.3390/ph5080802 · Cited by 39
Hildner, K., Finotto, S., Becker, C., Schlaak, J., Schirmacher, P., Galle, P. R., Märker‐Hermann, E., & Neurath, M. F. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.01022.x · Cited by 37
Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis.
Seideman, P., & Müller-Suur, R. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.8.613 · Cited by 37
Management of chikungunya arthritis
Pereira, J. K. A., & Schoen, R. T. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3766-7 · Cited by 35
Nesher, G., Osborn, T. G., & Moore, T. L. (1997) · PubMed · Cited by 34
Methotrexate: Still the anchor drug in RA treatment
Bijlsma, J. W. J., & Jacobs, J. W. G. (2009) · Joint Bone Spine · doi:10.1016/j.jbspin.2009.05.007 · Cited by 31
JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy
Vaddi, K., & Luchi, M. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.690029 · Cited by 31
Zhang, Y., Jiang, J., Xie, J., Xu, C., Wang, C., Yin, L. L., Yang, L., & Sung, K. ‐. P. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5264 · Cited by 30
Yuanbo, L., Xu, P., Xu, K., Cai, Y., Sun, M.-Y., Yang, L., Sun, J., & Lu, S. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2783-1 · Cited by 28
Emergence and treatment of chikungunya arthritis
Sutaria, R., Amaral, J. K., & Schoen, R. T. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000486 · Cited by 27
Nakajima, A., Hakoda, M., Yamanaka, H., Kamatani, N., & Kashiwazaki, S. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.4.237 · Cited by 26
Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis
Chen, Y., Jing, J., Mo, Y., Ma, J., Yang, L., Chen, L., Zhang, X., Yan, T., Zheng, D.-H., Peßler, F., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1623-y · Cited by 17
A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg.
Brennan, F. M. (2001) · Arthritis Research · doi:10.1186/ar302 · Cited by 11
Cited by
Strangfeld, A., Schäfer, M., Gianfrancesco, M. A., Lawson-Tovey, S., Liew, J. W., Ljung, L., Mateus, E. F., Richez, C., Santos, M. J., Schmajuk, G., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219498 · Cited by 667
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Spada, A., Emami, J., Tuszynski, J. A., & Lavasanifar, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00046 · Cited by 591
Persistent Joint Pain Following Arthropod Virus Infections
Suchowiecki, K., Reid, S. P., Simon, G. L., Firestein, G. S., & Chang, A. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-00987-y · Cited by 37
Metadata
- Authors
- Bedoui, Y., Guillot, X., Sélambarom, J., Guiraud, P., Giry, C., Jaffar-Bandjee, M. C., Ralandison, S., & Gasque, P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-10-10
- Volume
- 20
- Issue
- 20
- Pages
- 5023
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2979313800
- Cited by
- 471
- References
- 160
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.